發(fā)展情況.jpg)
Zhang Gaoli has investigated the high-end equipment manufacturing development in the GSK CNC EQUIPMENT CO., LTD. (Picture/Reporter from Xinhua Network Wang Ye)
CCTV reports this issue about GSK during the investigation of Mr. Zhang (Picture/CCTV NEWS)
30thNovember, when the CPC Central Committee Political Bureau Standing Committee, Vice Premier, Zhang Gaoli, investigated the works of the “B & R” Establishment, the Construction of Free Trade Test Zone and the Innovation Driving Development at Guangdong Province, he who has visited the R&D staffs in GSK, as well he has comprehended the development of High-end equipment manufacturing in Guangdong Province. Zhang Gaoli with his group visit the GSK’s Robot, Full-Electric Injection Molding Machine and CNC System, etc.
Zhang Gaoli indicates that the Innovation is the only way for the national development. We should regard the innovation as the first power of the development based upon the policy arrangement of the Central, and strive to portray more Leading-Developments based upon the innovation driving and First-Moving Advantage. We should tightly hold the technological innovation to strengthen the basement research, to consolidate the original innovation, integrated innovation and re-innovation for introducing the digestion and absorption. We should push forward the Mass Entrepreneurship & Mass Innovation, implement the “Internet” planning & “Made in China 2025” and enhance the booming developments of the new technology, new industry and fresh status. As well, we should strengthen the enterprise’s innovation main position and rapidly form a group of innovation leading enterprises with international competitiveness.
The Chairman of GSK, He Minjia, indicates that GSK has already marched to the industry robot in 2006. We hold the entirely the independent intellectual property rights for the Robot Controller, Servo Drive and Servo motor based upon the independent innovation and the search of several years, as well on the base of the technology accumulation of the abundant CNC machines. Therefore, a series of independent developments have completed, and the Robot businesses are developed into the “Leader” from the previous “Follower”, “Parallel Walker”. GSK owns the first-class production equipment and process flow in domestic. At present, the yields of CNC systems are ranged at the No.1 with the 10 consecutive years, which accounts for a half share compared with the similar products at home.
As for this investigation, Zhang Gaoli treats the GSK as one of the important investigation enterprise. GSK is always abide by the science innovation as a motivation, pursuit the excellent quality as a goal and dedicated to the research and practice of the intelligent device development.
In the wave of the “Made in China 2025”, simultaneously, when the robots from abroad are occupied the domestic markets, GSK makes a significant contribution for building the National Brand in the China’s Robot Industry, which depends on industry robots and advanced technology level at home of the entirely independent property right.